FR4384M - - Google Patents
Info
- Publication number
- FR4384M FR4384M FR19843A FR19843A FR4384M FR 4384 M FR4384 M FR 4384M FR 19843 A FR19843 A FR 19843A FR 19843 A FR19843 A FR 19843A FR 4384 M FR4384 M FR 4384M
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR19843A FR4384M (el) | 1965-06-08 | 1965-06-08 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR19843A FR4384M (el) | 1965-06-08 | 1965-06-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
FR4384M true FR4384M (el) | 1966-08-29 |
Family
ID=85686376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR19843A Expired FR4384M (el) | 1965-06-08 | 1965-06-08 |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR4384M (el) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986004815A2 (en) * | 1985-02-19 | 1986-08-28 | Board Of Regents, The University Of Texas System | Liquid dietary calcium supplementation |
WO1986004814A2 (en) * | 1985-02-19 | 1986-08-28 | Board Of Regents, The University Of Texas System | Osteoporosis inhibition by dietary calcium supplementation |
US4814177A (en) * | 1986-03-18 | 1989-03-21 | Board Of Regents, University Of Texas System | Ultradense and more soluble and bioavailable preparations of calcium citrate |
US4851221A (en) * | 1985-02-19 | 1989-07-25 | Mission Pharmacal Company | Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid |
US5314919A (en) * | 1987-08-28 | 1994-05-24 | The Procter & Gamble Company | Calcium supplements |
-
1965
- 1965-06-08 FR FR19843A patent/FR4384M/fr not_active Expired
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986004815A2 (en) * | 1985-02-19 | 1986-08-28 | Board Of Regents, The University Of Texas System | Liquid dietary calcium supplementation |
WO1986004814A2 (en) * | 1985-02-19 | 1986-08-28 | Board Of Regents, The University Of Texas System | Osteoporosis inhibition by dietary calcium supplementation |
WO1986004815A3 (en) * | 1985-02-19 | 1986-11-06 | Univ Texas | Liquid dietary calcium supplementation |
WO1986004814A3 (en) * | 1985-02-19 | 1986-11-06 | Univ Texas | Osteoporosis inhibition by dietary calcium supplementation |
US4772467A (en) * | 1985-02-19 | 1988-09-20 | Board Of Regents, U T Systems | Osteoporosis inhibition by dietary calcium supplementation |
AU578139B2 (en) * | 1985-02-19 | 1988-10-13 | Board Of Regents, The University Of Texas System | Osteoporosis inhibition by dietary calcium supplementation |
US4851221A (en) * | 1985-02-19 | 1989-07-25 | Mission Pharmacal Company | Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid |
US4814177A (en) * | 1986-03-18 | 1989-03-21 | Board Of Regents, University Of Texas System | Ultradense and more soluble and bioavailable preparations of calcium citrate |
US5314919A (en) * | 1987-08-28 | 1994-05-24 | The Procter & Gamble Company | Calcium supplements |